Abstract
Telcagepant (MK-0974) is a novel calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck.com/research/pipeline/home.html). MK-0974 is currently being studied in phase III clinical trials.
Original language | English (US) |
---|---|
Pages (from-to) | 334-335 |
Number of pages | 2 |
Journal | ACS Chemical Neuroscience |
Volume | 2 |
Issue number | 7 |
DOIs | |
State | Published - Jul 20 2011 |
Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry
- Physiology
- Cognitive Neuroscience
- Cell Biology